MOUSCRON PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MOUSCRON PHARMA
Largest movements
- Receivables within one year -€205,137
down €205,137 (-10.4%), from €2.0m to €1.8m
of which Trade receivables: -€168,270
- Stocks and contracts +€154,573
up €154,573 (+24.8%), from €622,050 to €776,623
- Tangible fixed assets -€101,311
down €101,311 (-14.9%), from €680,421 to €579,110
of which Land and buildings: -€70,529
- Trade debts -€206,042
down €206,042 (-14.8%), from €1.4m to €1.2m
- Reserves +€70,063
up €70,063 (+3.6%), from €1.9m to €2.0m
- Gross operating margin -€48,433
down €48,433 (-13.5%), from €358,760 to €310,327
- Staff costs -€40,581
down €40,581 (-21.1%), from €192,429 to €151,848
- Financial income -€22,469
down €22,469 (-32.8%), from €68,554 to €46,085
- Taxes -€7,555
down €7,555 (-23.0%), from €32,833 to €25,278
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,393,753 | €3,248,362 | -€145,390 | -4.3% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €680,421 | €579,110 | -€101,311 | -14.9% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €680,421 | €579,110 | -€101,311 | -14.9% |
| Land and buildings | 22 | €608,963 | €538,434 | -€70,529 | -11.6% |
| Plant, machinery and equipment | 23 | €62,036 | €35,066 | -€26,970 | -43.5% |
| Furniture and vehicles | 24 | €9,423 | €5,610 | -€3,812 | -40.5% |
| Current assets | 29/58 | €2,713,331 | €2,669,252 | -€44,079 | -1.6% |
| Stocks and contracts in progress | 3 | €622,050 | €776,623 | +€154,573 | +24.8% |
| Stocks | 30/36 | €622,050 | €776,623 | +€154,573 | +24.8% |
| Amounts receivable within one year | 40/41 | €1,970,284 | €1,765,147 | -€205,137 | -10.4% |
| Trade receivables | 40 | €256,396 | €88,126 | -€168,270 | -65.6% |
| Other amounts receivable | 41 | €1,713,888 | €1,677,020 | -€36,867 | -2.2% |
| Cash at bank and in hand | 54/58 | €120,997 | €123,889 | +€2,892 | +2.4% |
| Deferred charges and accrued income | 490/1 | - | €3,593 | +€3,593 | |
| Total equity and liabilities | 10/49 | €3,393,753 | €3,248,362 | -€145,390 | -4.3% |
| Equity | 10/15 | €1,962,346 | €2,032,410 | +€70,063 | +3.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,943,746 | €2,013,810 | +€70,063 | +3.6% |
| Distributable reserves | 133 | €1,943,746 | €2,013,810 | +€70,063 | +3.6% |
| Amounts payable | 17/49 | €1,431,406 | €1,215,953 | -€215,454 | -15.1% |
| Amounts payable within one year | 42/48 | €1,431,406 | €1,215,953 | -€215,454 | -15.1% |
| Trade debts | 44 | €1,396,049 | €1,190,007 | -€206,042 | -14.8% |
| Suppliers | 440/4 | €1,396,049 | €1,190,007 | -€206,042 | -14.8% |
| Taxes, remuneration and social security | 45 | €35,357 | €25,945 | -€9,412 | -26.6% |
| Taxes | 450/3 | €18,477 | €8,111 | -€10,366 | -56.1% |
| Remuneration and social security | 454/9 | €16,880 | €17,834 | +€954 | +5.7% |
| Remuneration, social security and pensions | 62 | €192,429 | €151,848 | -€40,581 | -21.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €101,751 | €101,311 | -€440 | -0.4% |
| Other operating charges | 640/8 | €6,208 | €6,198 | -€9 | -0.2% |
| Non-recurring operating charges | 66A | €548 | - | -€548 | |
| Gross operating margin | 9900 | €358,760 | €310,327 | -€48,433 | -13.5% |
| Operating profit (loss) | 9901 | €57,824 | €50,970 | -€6,855 | -11.9% |
| Financial income | 75/76B | €68,554 | €46,085 | -€22,469 | -32.8% |
| Recurring financial income | 75 | €68,554 | €46,085 | -€22,469 | -32.8% |
| Financial charges | 65/66B | €1,083 | €1,712 | +€630 | +58.2% |
| Recurring financial charges | 65 | €1,083 | €1,712 | +€630 | +58.2% |
| Profit (loss) for the period before taxes | 9903 | €125,295 | €95,342 | -€29,953 | -23.9% |
| Income taxes | 67/77 | €32,833 | €25,278 | -€7,555 | -23.0% |
| Profit (loss) for the period | 9904 | €92,462 | €70,063 | -€22,399 | -24.2% |
| Profit (loss) for the period to be appropriated | 9905 | €92,462 | €70,063 | -€22,399 | -24.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.